Stock Events

Stock Events

HCW Biologics 

$2.57
40
+$0.26+11.37% 18:09 Today

Statistics

Day High
2.89
Day Low
2.28
52W High
39.96
52W Low
1.5
Volume
263,557
Avg. Volume
163,557
Mkt Cap
4.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-11.58
-6.52
-1.46
3.6
Expected EPS
-1.08
Actual EPS
N/A

Financials

-41,294.44%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
54,000Revenue
-22.3MNet Income

Analyst Ratings

5.00Average Price Target
The highest estimate is 5.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HCWB. It's not an investment recommendation.
Apple
9
AAPL
NVIDIA
9
NVDA
Microsoft
7
MSFT
Realty Income
7
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap57.94B
Moderna is a leader in mRNA technology, directly competing in the biotech space for developing innovative therapies, similar to HCW Biologics' focus on novel treatments.
BioNTech
BNTX
Mkt Cap29.28B
BioNTech competes in the biopharmaceutical field, focusing on personalized medicine and vaccines, overlapping with HCW Biologics' therapeutic development.
Novavax
NVAX
Mkt Cap1.47B
Novavax is involved in the development of vaccines for infectious diseases, competing with HCW Biologics in the broader biotech and vaccine market.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a large pharmaceutical company with a wide range of products, including biologics, making it a competitor in the healthcare and biotech industry.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of innovative treatments, including biologics, which is HCW Biologics' focus.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences is a biopharmaceutical company that focuses on antiviral drugs and other treatments, competing with HCW Biologics in the biotech space.
AMGEN
AMGN
Mkt Cap237.52B
Amgen is a biotechnology firm specializing in human therapeutics, with a product range that competes with HCW Biologics' therapeutic development efforts.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Regeneron Pharmaceuticals is known for its innovative biologic medicines, directly competing with HCW Biologics in the field of biopharmaceuticals.
Vertex Pharmaceuticals
VRTX
Mkt Cap138.91B
Vertex Pharmaceuticals focuses on creating new possibilities in medicine to cure diseases and improve people's lives, competing with HCW Biologics in the biotech innovation sector.

About

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Show more...
CEO
Hing C. Wong
Employees
35
Country
United States
ISIN
US40423R3030

Listings

XNAS
US
HCWB
BOATS
BOATS
HCWB.BOATS

0 Comments

Share your thoughts

FAQ

What is HCW Biologics stock price today?▼
The current price of HCWB is $2.57 USD — it has increased by +11.37% in the past 24 hours. Watch HCW Biologics stock price performance more closely on the chart.
What is HCW Biologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange HCW Biologics stocks are traded under the ticker HCWB.
Is HCW Biologics stock price growing?▼
HCWB stock has risen by +20.78% compared to the previous week, the month change is a +2.91% rise, over the last year HCW Biologics has showed a -92.27% decrease.
What is HCW Biologics market cap?▼
Today HCW Biologics has the market capitalization of 4.11M
When is the next HCW Biologics earnings date?▼
HCW Biologics is going to release the next earnings report on November 12, 2026.
What were HCW Biologics earnings last quarter?▼
HCWB earnings for the last quarter are -11.58 USD per share, whereas the estimation was -1.98 USD resulting in a -484.85% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HCW Biologics revenue for the last year?▼
HCW Biologics revenue for the last year amounts to 54,000 USD.
What is HCW Biologics net income for the last year?▼
HCWB net income for the last year is -22.3M USD.
How many employees does HCW Biologics have?▼
As of August 25, 2026, the company has 35 employees.
In which sector is HCW Biologics located?▼
HCW Biologics operates in the Health & Wellness sector.
When did HCW Biologics complete a stock split?▼
The last stock split for HCW Biologics was on June 30, 2026 with a ratio of 1:6.
Where is HCW Biologics headquartered?▼
HCW Biologics is headquartered in MIRAMAR, United States.